Vol 45, No 2 (2014)
Prace poglądowe / Reviews
Published online: 2014-04-01

open access

Page views 199
Article views/downloads 1390
Get Citation

Connect on Social Media

Connect on Social Media

Danazol – options of usage for the treatment of haematological diseases

Arkadiusz Macheta, Agnieszka Szymczyk1, Monika Podhorecka1
DOI: 10.1016/j.achaem.2014.04.005
Acta Haematol Pol 2014;45(2):184-189.

Abstract

Danazol is an attenuated synthetic hormone with weak androgenic effects. It has unique properties similar to those of corticosteroids and has a structure related to testosterone and ethisterone. Danazol is widely used for endometriosis and in mammary gland dysplasia treatment. Among the others, it can be also a therapeutical option for patients with autoimmunological disorders, such as immune thrombocytopenic purpura and autoimmune hemolytic anemia. The attempts of danazol therapy in neoplastic hematological proliferations were also reported. In this article we present the literature review of options of danazol usage in hematology.

Article available in PDF format

View PDF (Polish) Download PDF file